The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future
The ever-increasing burden of type 2 diabetes mellitus (T2DM) worldwide, has led to the emergence of several antidiabetes drugs with different modes of action. Incretin hormones and their effect on glucose metabolism and pathogenesis of T2DM has been a landmark discovery in the management of this in...
Saved in:
Main Author: | Juris J. Meier |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/3f80af6f0ce043bc92ebdb42b6a1472a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
by: Ekaterina Alekseevna Shestakova
Published: (2011) -
The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
by: Enrique Z. Fisman, et al.
Published: (2021) -
Incretin-based therapy: renal effects
by: Anton Ivanovich Korbut, et al.
Published: (2016) -
Incretins today: multiple effects and therapeutic potential
by: Oksana V. Tsygankova, et al.
Published: (2019) -
Vildagliptin: optimal control in type 2 diabetes mellitus treatment
by: Alexander Sergeevich Ametov
Published: (2015)